Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-07-13The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
-
CLINICAL_TRIALS study record update · 2022-07-12Clinical Outcomes and Characteristics of Critically Ill Patients With Influenza and COVID-19 Induced ARDS: a Retrospective, Matched Cohort Study
-
CLINICAL_TRIALS study record update · 2022-06-28A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
-
CLINICAL_TRIALS study record update · 2022-06-22Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA
-
CLINICAL_TRIALS study record update · 2022-06-08Prospective Multicentre Study to Determine Respiratory Microbiome Biomarkers for the Prognostic of Clinical Course of Influenza in Children
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-06-06Postmarketing Surveillance Study for Use of Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) Administered Via the Intramuscular Route in Subjects Aged 3 Years Old and Above in the Republic of Korea
-
CLINICAL_TRIALS study record update · 2022-05-25To Identify the Immunogenicity and Safety of Inavtivated Quadrivalent Influenza Virus Split Vaccine in Children Aged 3-8 Years With Two Doses and One Dose Pre-immunization
-
CLINICAL_TRIALS study record update · 2022-05-24Post-Licensure Database Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring
-
CLINICAL_TRIALS study record update · 2022-05-11A Multinational, Comparative Phase III Clinical Trial to Assess the Efficacy (Immunogenicity) and Safety of NBP607-QIV (0.5 mL) (Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine) in Children Aged 6 to 35 Months
-
CLINICAL_TRIALS study record update · 2022-05-05Extracorporeal Membrane Oxygenation in COVID-19, Influenza and ARDS of Other Ethiologies
-
CLINICAL_TRIALS study record update · 2022-04-29Audio Data Collection for Identification and Classification of Coughing
-
CLINICAL_TRIALS study record update · 2022-04-25Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Healthy Chinese Subjects Aged 18 to 59 Years
-
CLINICAL_TRIALS study record update · 2022-04-25Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam
-
CLINICAL_TRIALS study record update · 2022-04-25Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine in Children Aged 6 Months to 17 Years
-
CLINICAL_TRIALS study record update · 2022-04-22A Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of H10N8 Antigen mRNA in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2022-04-18Prevalence, Genetic Risk Factor and the Use of Intradermally-administered Inactivated Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
-
CLINICAL_TRIALS study record update · 2022-04-14Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
-
CLINICAL_TRIALS study record update · 2022-04-08Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Vaccine in Children Aged 6 to 17 Years (Inclusive)
-
CLINICAL_TRIALS study record update · 2022-04-05Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
-
CLINICAL_TRIALS study record update · 2022-03-31Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal- RCT #2
-
CLINICAL_TRIALS study record update · 2022-03-31A Clinical Trial to Assess Immunogencity and Safety of 2 Doses of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
-
CLINICAL_TRIALS study record update · 2022-03-28Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA vs. the Vaxigrip® Inactivated Influenza Split Vaccine Manufactured by Sanofi Pasteur, France, in Volunteers Aged 18-60 Years
-
CLINICAL_TRIALS study record update · 2022-03-18Effect of Influenza Vaccination or Infection on the Development of Protective Immunity in Children
-
CLINICAL_TRIALS study record update · 2022-03-18National Vaccine Adverse Event Reporting Survey to Determine the Etiology of Vaccine-Induced Injury
-
CLINICAL_TRIALS study record update · 2022-03-14A Prospective Household Study of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus Community Burden, Transmission Dynamics and Viral Interaction in South Africa (the PHIRST-C Study)